Skip to main content
. 2022 Aug 15;23(16):9134. doi: 10.3390/ijms23169134

Figure 3.

Figure 3

Metformin mitigated inflammatory alterations in obese mice. ND-fed lean and HFD-fed obese mice were subcutaneously inoculated with LLC cells over a course of three weeks. Three days after cell implantation, ND-fed lean mice were treated daily with saline vehicle through intraperitoneal injection (ND). HFD-fed obese mice were separated into two groups receiving daily intraperitoneal injections of a saline vehicle (HFD) or metformin (50 mg/kg, HFD/Metformin) for the final 18 days. The levels of WBCs (A), lymphocytes (B), neutrophils (C), soluble P-selectin (D), TGF-β1 (E) and HMGB1 (F) in blood samples were all determined. * p < 0.05 vs. ND and # p < 0.05 vs. HFD, n = 6.